As regulators of cell adhesion and invasion, MMP2 and MMP9 are closely involved in augmentation of the invasive capability of glioma cells and correlate with the degree of histologic malignancy and clinical outcome,27, 28, 29, 30, 31 whereas Ki67 indicates the proliferative ability of the tumor. This evidence concerns the gene MMP9 and central nervous system cancer.